# A Prospective Epidemiologic Study of ALK-Positive NSCLC in China

> **NCT02042105** · — · COMPLETED · sponsor: **Guangdong Association of Clinical Trials** · enrollment: 3649 (actual)

## Conditions studied

- Non-small-cell Lung Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02042105
- **Lead sponsor:** Guangdong Association of Clinical Trials
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11-11
- **Primary completion:** 2015-04-15
- **Final completion:** 2016-07-06
- **Target enrollment:** 3649 (ACTUAL)
- **Last updated:** 2017-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02042105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02042105, "A Prospective Epidemiologic Study of ALK-Positive NSCLC in China". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02042105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*